Skip to main content

Moderna has submitted a request for emergency authorization for its COVID-19 vaccine in children aged 6 months to 2 years and from 2 years to 5 years.

The request has been made to the U.S. Food and Drug Administration as well as international regulators, and if approved it would be the first COVID vaccine available to children under five (a Pfizer vaccine is already in use for children aged five and over).

The vaccine series would comprise two 25 microgram doses of Moderna's mRNA-1273 vaccine – less than the 100 mg adult dose – with Moderna saying interim results from its latest studies showed a "robust neutralizing antibody response in the 6 month to under 6 years of age group."

It's hoped that the vaccine could be made available by the summer.

The vaccines are about 51% effective at preventing infection from the omicron variant in kids under 2, and 37% effective among kids aged 2-5 years old. Vaccines have become less effective at preventing infection due to the onset of more contagious variants, but Moderna says the vaccine is highly effective at preventing serious infections – more so than with adult shots.

Per CNBC, Moderna says that adults have around 1,000 units of antibody after two shots, providing at least 70% protection against severe disease, but children in its study had 1,400-1,800 units of antibody after their two-dose regimen. None of the children included in its study were hospitalized.

Moderna is also developing a booster shot for children that targets omicron as well as the original strain.

"We are proud to share that we have initiated our EUA submission for authorization for our COVID-19 vaccine for young children," said Stéphane Bancel, Chief Executive Officer of Moderna.

"We believe mRNA-1273 will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against COVID-19 and will be especially welcomed by parents and caregivers."

Pfizer has been developing its own mRNA vaccine for 2-5 year olds, but authorization for this was delayed pending more data, after it appeared to be less effective against the omicron variant.

Next Up

Train Days

Historic locomotives to roll into St. Paul for Train Days

The festival at the Union Depot returns June 4-5.

Dalton tornado

Tornadoes, large hail, damaging wind possible in Sunday/Monday storms

The Twin Cities is among the areas that could get hit.

Redtail Ridge Elementary

Sunbather on the roof triggers shelter-in-place at Savage elementary school

The sunbather told police he was trying to "tan and relax."


The Raptor Center's ambassador, Nero the turkey vulture, dies at 47

Nero helped save the California condors before taking up his post as an education ambassador.

Ben Leber

Ben Leber named new permanent co-host of 'Twin Cities Live'

The former Minnesota Vikings linebacker was introduced Friday afternoon.


APM Reports, maker of 'In the Dark' podcast, nixed by Minnesota Public Radio

MPR said "select programming elements" of APM Reports will be incorporated into MPR News.

storm, severe

The latest on holiday weekend severe weather chances for MN

The most significant severe threats are Sunday night and again on Monday.

Arianna Vos

Charges: Driver was drunk, high in head-on crash that killed 19-year-old woman

The young woman killed in the crash was a college student studying zoology.


Wikimedia Commons - COVID vaccine, pfizer, shot - Martin G

FDA authorizes Pfizer COVID vaccine for young teens

During the clinical trial, none of the participants that received the vaccine were diagnosed with the virus.

Wikimedia Commons - COVID vaccine, pfizer, shot - Martin G

FDA grants emergency use of COVID-19 booster shot for immunocompromised

A booster shot would serve as a third dose of the Moderna or Pfizer-BioNTech vaccine.

moderna vaccine covid

Drug trial shows Moderna vaccine is 96% effective in teens

The drugmaker still needs federal authorization following more studies.

flu shot, vaccine

Moderna says its COVID-19 vaccine appears to be 94.5% effective

It can be stored at a much warmer temperature than Pfizer's vaccine too.

vaccine, covid

Moderna vaccine set to arrive in MN Wednesday, will head to long-term care

The first priority group is expected to be vaccinated by the end of January.


Osterholm recommends delaying 2nd doses of COVID-19 vaccine

Delaying the second dose would allow more people to get a first dose of the vaccine.

Wikimedia Commons - COVID vaccine, pfizer, shot - Martin G

Pfizer to seek emergency use authorization to vaccinate kids ages 5 to 11

Pfizer says clinical trials have revealed positive results.